Challenges encountered by human immunodeficiency virus positive pregnant women on taking antiretrovirals in a public health unit of the Manzini region, Swaziland

Trusty L. Mbatha, Debbie SK. Habedi

Abstract

In Swaziland, the Ministry of Health adopted the prevention of mother-to-transmission (PMTCT) Option A as a feasible and less costly way to expand the PMTCT services nationwide. Despite major success since the programme started, some barriers, such as the challenge of follow-up care for human immunodeficiency virus (HIV)-positive pregnant mothers still exist. The present study aimed to describe the challenges that HIV-positive pregnant mothers encountered on taking antiretrovirals (ARVs) in a health unit of the Manzini region, Swaziland. A qualitative, exploratory and descriptive research design was used, and data were collected through semi-structured individual interviews and field notes. Purposive sampling was used to select the study site and the population. Permission was requested from the participants to record the interviews. The study population were HIV-positive pregnant mothers, aged between 18 and 40 years, which were enrolled in the PMTCT B+ programme. The PMTCT B+ programme was perceived as preventing the transfer of HIV transmission from mother to child. It boosts the mother’s immune system, prevents opportunistic infections and prolongs life. Challenges of taking ARVs emerged as a theme. The participants displayed knowledge and understanding of the programme, yet discrimination and no support from families and partners were mentioned. (Afr J Reprod Health 2022; 26[5]: 41-49).

Full Text:

PDF

References

Mamba HT and Hlongwana KW. Deterrents to Immediate Antiretroviral Therapy Initiation by Pregnant Women Living with HIV in Hhohho Region, Swaziland. African Journal of Reproductive Health December 2018; 22 (4):72. DOI:10.29063/ajrh2018/v22i4.8

Bhatti A, Usman M and Kandi V. Current Scenario of HIV/AIDS. Treatment Options, and Major Challenges with Compliance to Antiretroviral Therapy. Cureus 8(3): e515.DOI 10.7759/cureus.515. (March 01, 2016)

WHO: Antiretroviral therapy. Accessed: August 30, 2021. OR WHO: Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. (2015). Accessed: August 30, 2021

WHO: International drug monitoring: The role of national centers. Report of a WHO meeting. (1972). Accessed: 12 September 2021.

Olem D, Sharp KM, Taylor JM and Johnson MO: Overcoming barriers to HIV treatment adherence: A brief cognitive behavioural intervention for HIV-positive adults on antiretroviral treatment. Cogn Behav Pract. 2014, 21: 206-23.10.1016/j.cbpra.2013.09.003. 2014).

Meyers K, Qian H, Wu Y, Lao Y, Chen Q, Dong X, Li H, Yang Y, Jiang C and Zhou Z. Early Initiation of ARV During Pregnancy to Move towards Virtual Elimination of Mother-to-Child-Transmission of HIV-1 in Yunnan, China. PLos ONE. 2015; 10: e0138104.

HIV/AIDS UJUNPO.UNAIDS DATA 2017.UNAIDS/JC2910E.2017.

Vrazo AC, Sullivan D and Ryan PB. Eliminating Mother-to-Child Transmission of HIV by 2030:5 Strategies to Ensure Continued Progress. Global Health: Science and Practice. 2018; 6:249-56.

WHO. HIV/AIDS. Available at: https://www.who.int/nes-room/facts-in-pictures/detail/hiv-aids. Accessed 26 February 2021.

Mbatha TL and Dube A. HIV Positive Pregnant Mothers’ Perceptions and Experiences Regarding the Prevention of Mother-to-Child Transmission, Option B+ Program. Journal of Patient Experience Volume 8:1-7. (2021). DOI:10.1177/23743743735211065272.

Etoori D, Kerschberger B, Staderini N, Ndlangamandla M, Nhlabatsi B, Jobanputra K, Mthethwa-Hleza S, Parker LA, Sibanda S, Mabhena E, Pasipamire M, Kabore SM, Ruch B, Jamet C, Ciglenecki I and Teck R. Challenges and successes in the implementation of option B+ to prevent mother-to-child transmission of HIV in southern Swaziland. BMC Public Health. (2018). 18.374 https://doi.org/10.1186/s12889-018-5258-3.

Creswell JW. Research Design: Qualitative, Quantitative and Mixed Methods Approaches 4th ed.London: Sage Publications Ltd. 2014

Polit DF and Beck CT. Generating and Assessing Evidence for Nursing practice. 10th edition. Wolters Kluver. 2017.

Swaziland Ministry of Health. The Second National Health Sector Strategic Plan 2014-2018. Towards attainment of Universal Health Coverage. Draft Zero 29 August 2014. MHO.

Swaziland Government Ministry of Health. 2015. Swaziland national family planning service guidelines. Swaziland: MOH.

Buregyeya E, Naigino R, Mukose A, Makumbi F, Esiru G, Arinaitwe J, Musinguzi J and Wanyenze RK. BMC Pregnancy and Childbirth. (2017) 17:94 DOI 10.1186/s 1 2884-017-1276-x.

Ministry of Health, Kingdom of Swaziland. 2016. Nurses-Led ART Initiation in Swaziland. Participants’ workbook. Swaziland: SNAP.

WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2016. Available at: http://www.who.int/hiv/pub/arv/arv-2016/en/. Accessed September 21, 2021.

Londeree SJ, Norris TA, Courtney M, Jan C and Jesse KJ. Use of Antiretroviral Therapy During Pregnancy and Adverse B JAIDS Journal of Acquired Immune Deficiency Syndromes: September 1, 2018-Volume 79-Issue 1-p1-9. Doi:10.1097/QAI.0000000000001770. Available from: https: journals.1ww.com/jaids/FullText/2018/09010/. Accessed 21

September 2021.

Kim MH, Zhou A, Mazenga, Ahmed S, Markham C, Zomba G, Simon K, Kazembe PM and Abrams EJ. Why Did I Stop? Barriers and Facilitators to Uptake and Adherence to ART in Option B+ HIV Care in Lilongwe, Malawi. PLos ONE. 2016; 11.

Dlamini-Simelane TT and Moyer E. ‘Lost to follow up’: rethinking delayed and interrupted HIV treatment among married Swazi women. Health Policy Plan 2016;32 (2):248-56.

Ejigu Y and Tadesse B. HIV testing during pregnancy for prevention of mother-to-child transmission of HIV in Ethiopia. PLoS ONE; 2018 13(8): e0201886. Httpps://doi.org/10.1371/journal.pone.0201886.

Adera A, Wudu M, Yimam Y, Kidane M, Woreta A and Molla T. Assessment of Male Partner’s Involvement in Prevention of Mother-to-Child Transmission of HIV Associated Factors Among Males in PMTCT Services. American Journal of Health Research. Vol. 3, No. 4, 2015, pp.221-231. Doi: 10.11648/ajhr.20150304.14.

Pell C, Vernooij, E, Masilela N, Simelane N, Shabalala F and Reis, R. False starts in ‘test and start’: a qualitative study of reasons for delayed antiretroviral therapy in Swaziland. Int Health 2018; 10: 78-83 doi:10.1093/inthealth/ihx065 Advance Access publication 12 January 2018. Accessed: September 21, 2021.

Horter S, Thabede Z, Dlamini V, Bernays S, Stringer B, Mazibuko S, Dube L, Rusch B and Jobanputra K. ‘Life is so easy on ART, once you accept it’: acceptance, denial and linkage to HIV care in Shiselweni, Swaziland. Soc Sci Med 2017; 76:52-9.

Pell C, Reis R, Dlamini N, Moyer E and Vernooij E. ‘Then her neighbor will not know her status’: how health providers advocate antiretroviral therapy under universal test and treat. Int Health 2019; 11: 36-41. Doi:10.1093/inthealth/ihy058 Advance Access publication 18 August 2018.

Refbacks

  • There are currently no refbacks.